Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A subanalysis of a post-marketing study (J-STEP/EL Study).

Kohei KakuYusuke NaitoMasayuki Senda Yuji KuriharaRyoji GunjiSeigo KakiuchiKazunori Utsunomiya

Published in: Journal of diabetes investigation (2019)

Our finding suggests that tofogliflozin could be safely and effectively used in elderly Japanese patients with type 2 diabetes mellitus, irrespective of the number of OADs and the use of insulin.

Keyphrases

type diabetes
systematic review
middle aged
metabolic syndrome
skeletal muscle
glycemic control